The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCHAL.L Regulatory News (CHAL)

  • There is currently no data for CHAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funding Update

20 May 2015 07:00

RNS Number : 7112N
Challenger Acquisitions Limited
20 May 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.

 

 

For Immediate Release

20 May 2015

Challenger Acquisitions Limited

("Challenger" or the "Company")

 

Funding update

 

Challenger Acquisitions Limited (LSE: CHAL), a company formed to undertake one or more acquisitions of target companies or businesses in the entertainment and leisure sectors with the particular focus on the attractions sector, is pleased to provide the following update on its proposed funding of up to £3 million by means of issue of convertible notes ("Notes") announced on 28 April 2015. The principal terms of the Notes are set out below.

 

Highlights:

 

- Total funds formally committed to date: £3,067,200.

 

- Total funds received by the Company to date: £2,217,200.

 

 

To date the Company has received £2,217,200 out of the total of £3,067,200 formally committed to and accordingly the Notes for the amount of £2,217,200 have been issued. The outstanding balance of £850,000 is expected within the next 25 days.

 

As previously announced, the funds from the Notes are for general balance sheet strength and, in accordance with Challenger's acquisition strategy, will be used to fund an acquisition or investment.

 

Mark Gustafson, the Company's Executive Chairman, said:

 

"We are very pleased that new investors and existing shareholders have provided additional capital for our Company. Whilst there may be additional demand for our funding instrument, we are keen to move forward with our acquisition strategy."

 

Principal terms of the Notes:

 

· The Notes are unlisted, unsecured, transferable and convertible with a twelve month maturity date.

· Interest is accrued at 12% per annum and payable quarterly, or upon conversion, in cash or in ordinary shares of the Company ("Ordinary Shares") at the Company's discretion.

· The Notes can be converted into Ordinary Shares at a price per Ordinary Share equal to the lower of:

(A) 50p ("Fixed Conversion Price"); and

(B) market price ("Market Price") less 7.5%.

Market Price is defined as the average of the lowest 3 VWAP as quoted by Bloomberg for the period of 10 trading days prior to the conversion date. Provided that if the Volume Weighted Average Price (VWAP) is at any time less than 25p for 3 consecutive trading days, then the noteholder is unable to convert for a period of 30 calendar days, without the consent of the Company. The requirement of consent applies only on the first such occasion.

· The maximum amount of Notes that may be converted in any 30 day period by a noteholder is 10% of the total amount of any Notes subscribed by that noteholder.

· Challenger can redeem the Notes at a 10% premium anytime the Market Price is lower than the Fixed Conversion Price.

There is an introduction or arrangement fee of up to 6% payable in cash or ordinary shares, at the Company's discretion.

 

For more information:

 

Challenger Acquisitions Limited

www.challengeracquisitions.com

Mark Gustafson, Executive Chairman

+1 604 454 8677

Beaumont Cornish Limited (Financial Adviser)

Roland Cornish

+44 (0) 20 7628 3396

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFETEEIALIE
Date   Source Headline
17th May 20167:00 amRNSResult of AGM
16th May 20167:00 amRNSPurchase of Shares by Director
9th May 20167:00 amRNSPurchase of Shares by Director
3rd May 20167:00 amRNSPurchase of Shares by Director
29th Apr 20167:00 amRNSTotal Voting Rights
28th Apr 20164:50 pmRNSAnnual Report and Notice of AGM
27th Apr 20167:00 amRNSFinal Results
26th Apr 20167:00 amRNSConvertible Notes Extension & Issue of £0.5m Note
13th Apr 20162:00 pmRNSAllotment of Shares re Convertible Loan Notes
31st Mar 20167:00 amRNSUpdate on Global Giant Observation Wheel Activity
24th Mar 20165:48 pmRNSFurther Re: Conversion of Convertible Loan Notes
21st Mar 20167:00 amRNSConversion of Convertible Loan Notes
9th Mar 201612:35 pmRNSPresenting at Shares Investor Evening
3rd Mar 20167:00 amRNSIssue of £0.5m convertible notes
22nd Feb 20167:00 amRNSUpdate on Giant Observation Wheel in Jakarta
5th Feb 20167:00 amRNSHolding(s) in Company
29th Jan 20165:00 pmRNSTotal Voting Rights
29th Jan 20167:00 amRNSIncreases Investment in New York Wheel
15th Jan 20167:00 amRNSAppointment of Financial Adviser
12th Jan 20167:00 amRNSAppointment of New Directors
7th Jan 20163:51 pmRNSAllotment of Shares and Options Granted
8th Dec 20158:00 amRNSReadmission to trading on London Stock Exchange
8th Dec 20158:00 amRNSCancellation - Challenger Acquisitions Limited
2nd Dec 20152:11 pmRNSPublication of Prospectus & Expected Readmission
30th Oct 201511:52 amRNSTotal Voting Rights
10th Sep 20155:30 pmRNSGrant of Options and Prospectus Update
28th Aug 20153:33 pmRNSHalf Yearly Report
5th Aug 201512:42 pmRNSHolding(s) in Company
30th Jul 20152:55 pmRNSFunding update, grant of options & issue of equity
21st Jul 20151:14 pmRNSHolding(s) in Company
16th Jul 20158:00 amRNSAcquisition of Starneth Completed
7th Jul 201512:34 pmRNSIssue of Equity
27th May 20153:31 pmRNSHolding(s) in Company
26th May 20159:25 amRNSInvestment, LOI and suspension
26th May 20159:10 amRNSSuspension Challenger Acquisitions Limited
20th May 20157:00 amRNSFunding Update
13th May 20155:23 pmRNSHolding(s) in Company
28th Apr 20158:00 amRNSProposed funding: up to £3m via convertible notes
7th Apr 201510:10 amRNSUK Investor Show
2nd Apr 20154:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20154:35 pmRNSPrice Monitoring Extension
18th Mar 20158:00 amRNSCorporation Agreement with Starneth signed
19th Feb 20157:00 amRNSAdmission to Trading and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.